2071 Results

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Zelenetz
    Zelenetz
  4. Yahalom
    Yahalom
  5. Cheung
    Cheung
  6. O'Reilly
    O'Reilly
  7. Kushner
    Kushner
  8. Perales
    Perales
  9. La Quaglia
    La Quaglia
  10. Giralt
    Giralt

Groups

  1. Department of Medicine (1047)
  2. Center for Hematologic Malignancies (589)
  3. Hematologic Malignancies, Division of (537)
  4. Survivorship Research (532)
  5. Solid Tumor Oncology Division (487)
  6. Pediatrics, Department of (383)
  7. Surgery (287)
  8. GSK Faculty (276)
  9. Breast Medicine Service (255)
  10. Tow Center for Developmental Oncology (TCDO) (240)
  1. "cyclophosphamide"
Formats
  1. Journal Article (1932)
  2. Review (52)
  3. Conference Paper (46)
  4. Editorial (11)
  5. Research Letter (11)
  6. Meeting Abstract (8)
  7. Correspondence (6)
  8. Guidelines (4)
  9. Book Section (1)
Groups
  1. Department of Medicine (1047)
  2. Center for Hematologic Malignancies (589)
  3. Hematologic Malignancies, Division of (537)
  4. Survivorship Research (532)
  5. Solid Tumor Oncology Division (487)
  6. Pediatrics, Department of (383)

More Groups

People
  1. Clifford Hudis (130)
  2. Larry Norton (104)
  3. Andrew Zelenetz (75)
  4. Joachim Yahalom (72)
  5. Nai-Kong Cheung (71)
  6. Richard O'Reilly (67)

More People

Years
  1. 2025 (45)
  2. 2024 (86)
  3. 2023 (56)
  4. 2022 (44)
  5. 2021 (23)
  6. 2020 (46)

More Years

Publications
  1. Journal of Clinical Oncology (155)
  2. Cancer (109)
  3. Blood (81)
  4. Leukemia and Lymphoma (50)
  5. Biology of Blood and Marrow Transplantation (49)
  6. Bone Marrow Transplantation (48)

More Publications

Publishers
  1. Elsevier Inc. (345)
  2. American Society of Clinical Oncology (163)
  3. Wiley Blackwell (150)
  4. Springer (147)
  5. American Society of Hematology (113)
  6. Lippincott Williams & Wilkins (112)

More Publishers

Results (2071)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Five-year follow-up of SWOG S0816: Limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma
    Journal Article

    Stephens, D. M.; Li, H.; Schöder, H.; Straus, D. J.; Moskowitz, C. H.; LeBlanc, M.; Rimsza, L. M.; Bartlett, N. L.; Evens, A. M.; LaCasce, A. S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia
    Journal Article

    Bejanyan, N.; Kim, S.; Hebert, K. M.; Kekre, N.; Abdel-Azim, H.; Ahmed, I.; Aljurf, M.; Badawy, S. M.; Beitinjaneh, A.; Boelens, J. J.; more...
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
    Journal Article

    Ramachandran, I.; Lowther, D. E.; Dryer-Minnerly, R.; Wang, R.; Fayngerts, S.; Nunez, D.; Betts, G.; Bath, N.; Tipping, A. J.; Melchiori, L.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Clinical applications of breast cancer metabolomics using high-resolution magic angle spinning proton magnetic resonance spectroscopy (HRMAS 1H MRS): Systematic scoping review
    Journal Article

    Bitencourt, A. G. V.; Goldberg, J.; Pinker, K.; Thakur, S. B.
    Metabolomics (2019)

    Fulltext@MSK | Save
  • Assessment of pulmonary outcomes, exercise capacity, and longitudinal changes in lung function in pediatric survivors of high-risk neuroblastoma
    Journal Article

    Stone, A.; Friedman, D. N.; Kushner, B. H.; Wolden, S.; Modak, S.; LaQuaglia, M. P.; Costello, J.; Wu, X.; Cheung, N. K.; Sklar, C. A.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Safety and feasibility of chimeric antigen receptor T cell therapy after allogeneic hematopoietic cell transplantation in relapsed/refractory B cell non-Hodgkin lymphoma
    Journal Article

    Jain, T.; Sauter, C. S.; Shah, G. L.; Maloy, M. A.; Chan, J.; Scordo, M.; Avecilla, S. T.; Batlevi, Y.; Dahi, P. B.; Batlevi, C. W.; more...
    Leukemia (2019)

    Fulltext@MSK | Save
  • Lymphocyte-to-monocyte ratio may serve as a better prognostic indicator than tumor-associated macrophages in DLBCL treated with rituximab
    Journal Article

    Matsuki, E.; Bohn, O. L.; El Jamal, S.; Pichardo, J. D.; Zelenetz, A. D.; Younes, A.; Teruya-Feldstein, J.
    Applied Immunohistochemistry & Molecular Morphology (2019)

    Fulltext@MSK | Save
  • Survival outcomes of allogeneic hematopoietic cell transplants with EBV-positive or EBV-negative post-transplant lymphoproliferative disorder, A CIBMTR study
    Journal Article

    Naik, S.; Riches, M.; Hari, P.; Kim, S.; Chen, M.; Bachier, C.; Shaughnessy, P.; Hill, J.; Ljungman, P.; Battiwalla, M.; more...
    Transplant Infectious Disease (2019)

    Fulltext@MSK | Save
  • Increased local failure for patients with intermediate-risk rhabdomyosarcoma on ARST0531: A report from the Children's Oncology Group
    Journal Article

    Casey, D. L.; Chi, Y. Y.; Donaldson, S. S.; Hawkins, D. S.; Tian, J.; Arndt, C. A.; Rodeberg, D. A.; Routh, J. C.; Lautz, T. B.; Gupta, A. A.; more...
    Cancer (2019)

    Fulltext@MSK | Save
  • Related and unrelated donor transplantation for β-thalassemia major: Results of an international survey
    Journal Article

    Li, C.; Mathews, V.; Kim, S.; George, B.; Hebert, K.; Jiang, H.; Li, C.; Zhu, Y.; Keesler, D. A.; Boelens, J. J.; more...
    Blood Advances (2019)

    Fulltext@MSK | Save